Edition:
United States

Endocyte Inc (ECYT.OQ)

ECYT.OQ on NASDAQ Stock Exchange Global Select Market

23.57USD
1:53pm EST
Change (% chg)

$-0.05 (-0.21%)
Prev Close
$23.62
Open
$23.60
Day's High
$23.62
Day's Low
$23.56
Volume
194,585
Avg. Vol
556,926
52-wk High
$23.87
52-wk Low
$2.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.09 -0.175
Jun '18 0.01 -0.166
Mar '18 0.02 -0.156
FY 2017 Dec '17 0.01 -0.178
Sep '17 0.03 -0.546
Jun '17 0.01 -0.276
Mar '17 0.01 -0.271
FY 2016 Dec '16 0.01 -0.262
Sep '16 0.03 -0.206
Jun '16 0.01 -0.331
Mar '16 0.01 -0.241
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.02 0.02 0.01 0.00
Quarter Ending Mar-19 3 0.01 0.02 0.00 --
Year Ending Dec-18 3 0.09 0.10 0.08 0.00
Year Ending Dec-19 4 0.06 0.10 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 3 -0.16 -0.15 -0.17 -0.34
Quarter Ending Mar-19 3 -0.17 -0.15 -0.18 --
Year Ending Dec-18 3 -0.66 -0.64 -0.67 -0.90
Year Ending Dec-19 4 -0.68 -0.62 -0.76 -0.86
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 79.36 29.34
P/E High - Last 5 Yrs. 48.11 265.87 45.80
P/E Low - Last 5 Yrs. 48.11 84.08 25.31
Beta 0.02 0.73 0.91
Price to Sales (TTM) 15,041.18 217.50 20.58
Price to Book (MRQ) 5.52 16.40 4.23
Price to Tangible Book (MRQ) 5.58 20.76 12.86
Price to Cash Flow (TTM) -- 48.38 21.19
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.65
Dividend Yield - 5 Year Avg -- 0.23 1.43
Dividend 5 Year Growth Rate -- 3.73 -8.12
Payout Ratio(TTM) -- 7.92 43.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 164.18 147.95 6.76
Sales (TTM) vs TTM 1 Yr. Ago 83.84 61.16 5.37
Sales - 5 Yr. Growth Rate -71.09 22.11 7.50
EPS (MRQ) vs Qtr. 1 Yr. Ago 67.93 79.14 28.07
EPS (TTM) vs TTM 1 Yr. Ago 50.12 -- --
EPS - 5 Yr. Growth Rate -- 20.47 7.61
Capital Spending - 5 Yr. Growth Rate -46.39 34.50 8.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.42 2.60
Current Ratio (MRQ) 45.77 6.52 3.62
LT Debt to Equity (MRQ) 0.00 18.23 9.93
Total Debt to Equity (MRQ) 0.00 24.16 13.84
Interest Coverage (TTM) -- -167.47 35.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.41 53.45
Gross Margin - 5 Yr. Avg. -- 47.56 52.35
EBITD Margin (TTM) -33,311.27 -- --
EBITD - 5 Yr. Avg -112.12 -157.37 16.18
Operating Margin (TTM) -33,947.76 -1,765.04 -12.21
Operating Margin - 5 Yr. Avg. -115.27 -170.51 11.72
Pre-Tax Margin (TTM) -32,122.81 -1,697.73 -10.76
Pre-Tax Margin - 5 Yr. Avg. -112.82 -173.18 12.03
Net Profit Margin (TTM) -32,122.81 -1,693.59 -14.16
Net Profit Margin - 5 Yr. Avg. -112.82 -173.54 8.28
Effective Tax Rate (TTM) -- 14.72 21.78
Effective Tax Rate - 5 Yr. Avg. -- 19.72 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,925 24,455,577 843,943,000
Net Income/Employee (TTM) -939,519 -3,607,776 98,316,608
Receivable Turnover (TTM) 3.39 8.35 5.42
Inventory Turnover (TTM) -- 2.90 4.00
Asset Turnover (TTM) 0.00 0.48 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -17.89 -0.72 10.84
Return on Assets - 5 Yr. Avg. -17.87 2.40 11.60
Return on Investment (TTM) -18.37 -0.30 13.58
Return on Investment - 5 Yr. Avg. -20.96 2.31 14.86
Return on Equity (TTM) -18.42 -2.98 15.11
Return on Equity - 5 Yr. Avg. -21.85 -1.50 16.02
  1 Year 3 Year 5 Year
Sales % 0.00 -90.02 -71.09
EPS (TTM) % -20.64 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Endocyte Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 47.84 52.60 99 91
13 Week 44.22 50.46 99 93
26 Week 94.72 93.95 99 91
52 Week 412.61 386.75 99 98
YTD 450.93 441.10 99 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 90.53%
# of Holders: 195
Total Shares Held: 74,314,576
3 Mo. Net Change: 14,346,291
# New Positions: 47
# Closed Positions: 15
# Increased Positions: 106
# Reduced Positions: 61
# Net Buyers: 45
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.